Fortress Biotech Inc (FBIO)
1.75
-0.05
(-2.78%)
USD |
NASDAQ |
May 03, 16:00
1.76
+0.01
(+0.57%)
After-Hours: 20:00
Fortress Biotech Enterprise Value: -4.365M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | -4.365M |
| May 02, 2024 | -3.403M |
| May 01, 2024 | -4.557M |
| April 30, 2024 | -5.903M |
| April 29, 2024 | -4.942M |
| April 26, 2024 | -4.942M |
| April 25, 2024 | -4.942M |
| April 24, 2024 | -3.595M |
| April 23, 2024 | -3.211M |
| April 22, 2024 | -4.365M |
| April 19, 2024 | -4.365M |
| April 18, 2024 | -3.211M |
| April 17, 2024 | -3.980M |
| April 16, 2024 | -4.172M |
| April 15, 2024 | -3.018M |
| April 12, 2024 | -3.403M |
| April 11, 2024 | -3.018M |
| April 10, 2024 | -1.287M |
| April 09, 2024 | -1.672M |
| April 08, 2024 | -1.480M |
| April 05, 2024 | -2.056M |
| April 04, 2024 | -2.056M |
| April 03, 2024 | -1.095M |
| April 02, 2024 | -0.9024M |
| April 01, 2024 | 0.2517M |
| Date | Value |
|---|---|
| March 28, 2024 | 0.444M |
| March 27, 2024 | 3.714M |
| March 26, 2024 | -2.558M |
| March 25, 2024 | -2.925M |
| March 22, 2024 | -2.466M |
| March 21, 2024 | -1.823M |
| March 20, 2024 | -2.925M |
| March 19, 2024 | -3.201M |
| March 18, 2024 | -2.742M |
| March 15, 2024 | -2.466M |
| March 14, 2024 | -7.152M |
| March 13, 2024 | -4.579M |
| March 12, 2024 | -2.650M |
| March 11, 2024 | -1.271M |
| March 08, 2024 | 0.5663M |
| March 07, 2024 | 0.015M |
| March 06, 2024 | 2.680M |
| March 05, 2024 | 3.690M |
| March 04, 2024 | 4.058M |
| March 01, 2024 | 6.631M |
| February 29, 2024 | 0.1987M |
| February 28, 2024 | 2.036M |
| February 27, 2024 | -1.639M |
| February 26, 2024 | -4.028M |
| February 23, 2024 | -6.049M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-41.71M
Minimum
Nov 10 2023
444.49M
Maximum
Apr 12 2021
113.66M
Average
92.37M
Median
Oct 07 2019
Enterprise Value Benchmarks
| Journey Medical Corp | 60.73M |
| Avenue Therapeutics Inc | 0.1097M |
| Mustang Bio Inc | -2.932M |
| Checkpoint Therapeutics Inc | 51.46M |
| Viking Therapeutics Inc | 7.524B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.279M |
| Revenue (Quarterly) | 19.95M |
| Total Expenses (Quarterly) | 42.70M |
| EPS Diluted (Quarterly) | -0.526 |
| Gross Profit Margin (Quarterly) | 69.84% |
| Profit Margin (Quarterly) | -46.52% |
| Earnings Yield | -469.5% |
| Normalized Earnings Yield | -485.07 |